Gavi signs agreements with Sinopharm and Sinovac for immediate supply to COVAX
Unitaid statement on WHO recommendations for tocilizumab and sarilumab
Joint COVAX Statement on the equal recognition of vaccines
6 million children benefitting from the first ever multi-antigen vaccination campaign
Harare, 1 July 2021 – UNICEF, Gavi, the Vaccine Alliance and […]
Gavi signs agreement with Clover Biopharmaceuticals for supply to COVAX
-
Indonesia introduces Pneumococcal Conjugate Vaccine (PCV) across the country
-
Gavi, UNICEF and partners collaborate on nationwide introduction, which […]
Gavi Board strengthens commitment to reaching the most vulnerable through routine immunisation and COVAX
-
Gavi Board makes key strategic decisions to support Gavi’s […]
Gavi and the Global Fund sign groundbreaking agreement with International Federation of Accountants to support in-country financial management
- Geneva, 24 June 2021 – Global health leaders Gavi, the […]
What does COVAX’s latest supply forecast tell us?
23 June 2021 – by Aurélia Nguyen, Managing Director, Office of […]
-